Literature DB >> 8530416

Mutants in the putative nucleotide-binding region of the plasma membrane Ca(2+)-pump. A reduction in activity due to slow dephosphorylation.

H P Adamo1, A G Filoteo, A Enyedi, J T Penniston.   

Abstract

Mutants of individual residues of the plasma membrane Ca(2+)-pump were made in the highly conserved region that (in related P-type ATPases) has been associated with nucleotide binding. Alteration of the strictly conserved Asp672 to Glu nearly eliminated the ability of the pump to transport Ca2+, while alteration at Val674, Arg675, and Lys686 reduced the activity. High levels of ATP (25 mM) did not overcome the reduced activity, indicating that it could not be due to a reduction in the affinity for ATP. Effects not directly related to ATP binding seemed to result from mutations in this area. For instance, the amount of phosphorylated intermediate in the most severely inhibited mutant, Asp672-->Glu, was nearly as high as that in the wild type, a much larger amount of phosphorylated intermediate than was expected from its low activity. However, the rate of decomposition of this intermediate was much slower than that of the wild type, indicating that the inhibition of this mutant resulted from an inhibition of the E approximately P-->E step in the enzyme cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530416     DOI: 10.1074/jbc.270.50.30111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The plasma membrane Ca2+ pump mutant lysine591 --> arginine retains some activity, but is still inactivated by fluorescein isothiocyanate.

Authors:  H P Adamo; A G Filoteo; J T Penniston
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways.

Authors:  Mary Louisa Holton; Weiguang Wang; Michael Emerson; Ludwig Neyses; Angel L Armesilla
Journal:  World J Biol Chem       Date:  2010-06-26

3.  Plasma membrane calcium ATPase 4b inhibits nitric oxide generation through calcium-induced dynamic interaction with neuronal nitric oxide synthase.

Authors:  Wenjuan Duan; Juefei Zhou; Wei Li; Teng Zhou; Qianqian Chen; Fuyu Yang; Taotao Wei
Journal:  Protein Cell       Date:  2013-04-03       Impact factor: 14.870

4.  Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.

Authors:  Xu Wu; Baojun Chang; N Scott Blair; Michelle Sargent; Allen J York; Jeffrey Robbins; Gary E Shull; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

5.  The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I.

Authors:  K Schuh; S Uldrijan; M Telkamp; N Rothlein; L Neyses
Journal:  J Cell Biol       Date:  2001-10-08       Impact factor: 10.539

6.  Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt".

Authors:  Mateus H Gouveia; Andrew W Bergen; Victor Borda; Kelly Nunes; Thiago P Leal; Martin D Ogwang; Edward D Yeboah; James E Mensah; Tobias Kinyera; Isaac Otim; Hadijah Nabalende; Ismail D Legason; Sununguko Wata Mpoloka; Gaonyadiwe George Mokone; Patrick Kerchan; Kishor Bhatia; Steven J Reynolds; Richard B Birtwum; Andrew A Adjei; Yao Tettey; Evelyn Tay; Robert Hoover; Ruth M Pfeiffer; Robert J Biggar; James J Goedert; Ludmila Prokunina-Olsson; Michael Dean; Meredith Yeager; M Fernanda Lima-Costa; Ann W Hsing; Sarah A Tishkoff; Stephen J Chanock; Eduardo Tarazona-Santos; Sam M Mbulaiteye
Journal:  PLoS Genet       Date:  2019-03-08       Impact factor: 5.917

7.  Identification of Novel Genomic-Variant Patterns of OR56A5, OR52L1, and CTSD in Retinitis Pigmentosa Patients by Whole-Exome Sequencing.

Authors:  Ting-Yi Lin; Yun-Chia Chang; Yu-Jer Hsiao; Yueh Chien; Ying-Chun Jheng; Jing-Rong Wu; Lo-Jei Ching; De-Kuang Hwang; Chih-Chien Hsu; Tai-Chi Lin; Yu-Bai Chou; Yi-Ming Huang; Shih-Jen Chen; Yi-Ping Yang; Ping-Hsing Tsai
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.